Open-label Extension Study to Evaluate the Long-term Safety and Tolerability of Dupilumab in Patients With Asthma Who Participated in a Previous Dupilumab Asthma Clinical Study
Phase of Trial: Phase II/III
Latest Information Update: 25 Sep 2017
At a glance
- Drugs Dupilumab (Primary) ; Budesonide/formoterol; Mometasone/formoterol; Salmeterol/fluticasone propionate
- Indications Asthma
- Focus Adverse reactions
- Sponsors Sanofi
- 15 Jun 2017 Planned End Date changed from 1 Sep 2019 to 2 Oct 2019.
- 15 Jun 2017 Planned primary completion date changed from 1 Sep 2019 to 2 Oct 2019.
- 16 Mar 2017 Planned End Date changed from 1 Oct 2019 to 1 Sep 2019.